We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
-17.04%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.64B
AUM Growth
-$464M
Cap. Flow
-$102M
Cap. Flow %
-6.21%
Top 10 Hldgs %
89.74%
Holding
56
New
–
Increased
6
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$5.33M
2
MSFT icon
Microsoft
MSFT
+$499K
3
MTD icon
Mettler-Toledo International
MTD
+$325K
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$142K
5
MRNA icon
Moderna
MRNA
+$3.43K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$60.2M
2
EW icon
Edwards Lifesciences
EW
+$27.1M
3
QCOM icon
Qualcomm
QCOM
+$10.8M
4
COST icon
Costco
COST
+$3.67M
5
HD icon
Home Depot
HD
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 29.28%
2 Technology 24.47%
3 Financials 19.28%
4 Consumer Staples 10.95%
5 Communication Services 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
1
Mettler-Toledo International
MTD
$28.6B
$206M 12.54%
179,110
+259
+0.1% +$325K
COST icon
2
Costco
COST
$422B
$177M 10.76%
368,290
-7,241
-2% -$3.67M
IDXX icon
3
Idexx Laboratories
IDXX
$44.1B
$170M 10.38%
485,816
+13,064
+3% +$5.33M
V icon
4
Visa
V
$684B
$161M 9.81%
817,423
-5,841
-0.7% -$1.21M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.36T
$153M 9.33%
1,400,020
+1,200
+0.1% +$142K
CME icon
6
CME Group
CME
$96.3B
$152M 9.28%
743,589
-373
-0.1% -$79.1K
ADP icon
7
Automatic Data Processing
ADP
$106B
$144M 8.77%
684,880
-1,586
-0.2% -$348K
MSFT icon
8
Microsoft
MSFT
$3.45T
$138M 8.41%
537,028
+1,837
+0.3% +$499K
HD icon
9
Home Depot
HD
$331B
$95.6M 5.83%
348,544
-9,759
-3% -$2.88M
EW icon
10
Edwards Lifesciences
EW
$49.6B
$76.2M 4.65%
801,740
-262,179
-25% -$27.1M
QCOM icon
11
Qualcomm
QCOM
$155B
$73.3M 4.47%
573,929
-79,562
-12% -$10.8M
INTC icon
12
Intel
INTC
$455B
$24.4M 1.48%
651,163
-360
-0.1% -$15.6K
DHR icon
13
Danaher
DHR
$137B
$12.1M 0.74%
53,980
-1,322
-2% -$304K
AAPL icon
14
Apple
AAPL
$4.54T
$11.3M 0.69%
82,558
-54
-0.1% -$8.18K
AMD icon
15
Advanced Micro Devices
AMD
$776B
$6.33M 0.39%
82,722
– –
MRK icon
16
Merck
MRK
$322B
$5.67M 0.35%
62,183
– –
GILD icon
17
Gilead Sciences
GILD
$162B
$4.33M 0.26%
70,114
– –
XOM icon
18
ExxonMobil
XOM
$644B
$4.21M 0.26%
49,181
-920
-2% -$83K
PEP icon
19
PepsiCo
PEP
$190B
$2.25M 0.14%
13,503
– –
CI icon
20
Cigna
CI
$73.8B
$1.95M 0.12%
7,406
-867
-10% -$223K
ADI icon
21
Analog Devices
ADI
$179B
$1.8M 0.11%
12,349
– –
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.36T
$1.72M 0.1%
15,740
-100
-0.6% -$11.8K
MA icon
23
Mastercard
MA
$506B
$1.71M 0.1%
5,412
– –
IONS icon
24
Ionis Pharmaceuticals
IONS
$8.6B
$1.52M 0.09%
41,010
– –
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.31M 0.08%
4,817
– –
1
2 3

Similar funds

HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Capital Counsel's Q2 2022 Portfolio in Review

As of Q2 2022, Capital Counsel held 56 positions worth $1.64B, down 22% from $2.1B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Capital Counsel withdrew a net $102M in Q2 2022, closing 5 positions and reducing 18 holdings. Its most notable exit was Johnson & Johnson, an estimated $60.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Capital Counsel added an estimated $5.33M to Idexx Laboratories.

  • Capital Counsel added most to Idexx Laboratories in Q2 2022, an estimated $5.33M increase.
  • Capital Counsel's biggest Q2 2022 reduction was Edwards Lifesciences, cutting an estimated $27.1M.
  • Capital Counsel fully exited Johnson & Johnson in Q2 2022, selling an estimated $60.2M.
  • Capital Counsel's ten largest holdings make up 90% of its $1.64B portfolio in Q2 2022.
  • Capital Counsel opened 0 new positions and closed 5 in Q2 2022.
  • Capital Counsel's portfolio value fell 22% quarter-over-quarter to $1.64B.

Based on Capital Counsel's 13F filing for Q2 2022, filed 15 Aug 2022.